NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $279,000 | +17.2% | 20,657 | +56.1% | 0.03% | +6.2% |
| Q3 2021 | $238,000 | -65.5% | 13,231 | -67.1% | 0.03% | -65.2% |
| Q2 2021 | $689,000 | -14.9% | 40,156 | -0.9% | 0.09% | -18.6% |
| Q1 2021 | $810,000 | +27.8% | 40,506 | +8.6% | 0.11% | +18.9% |
| Q4 2020 | $634,000 | +3.1% | 37,306 | +0.7% | 0.10% | -6.9% |
| Q3 2020 | $615,000 | -26.7% | 37,056 | +2.3% | 0.10% | -31.5% |
| Q2 2020 | $839,000 | +57.7% | 36,231 | +21.7% | 0.15% | +33.0% |
| Q1 2020 | $532,000 | +25.8% | 29,781 | +51.9% | 0.11% | +62.3% |
| Q4 2019 | $423,000 | – | 19,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |